134 related articles for article (PubMed ID: 2903834)
21. The pharmacological characterization of beta-sympathicolytic substances.
Saameli K
Indian Heart J; 1972 Jun; 24():Suppl 1:146-56. PubMed ID: 4147272
[No Abstract] [Full Text] [Related]
22. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle.
Knezl V; Magna D; Sotníková R; Drímal J
Arzneimittelforschung; 1994 Jan; 44(1):7-12. PubMed ID: 7907875
[TBL] [Abstract][Full Text] [Related]
23. Derivatives of 2-mercaptobenzenesulphonamide. XVII. Synthesis and some pharmacological properties of 1-[4-R-5-cyano-2-dialkylaminoalkylthio)benzenesulphonyl]-2-imidiazolidi none hydrochlorides.
Pomarnacka E; Brzozowski Z; Gajewski F; Filczewski M; Oledzka K; Kosmala M; Sliwoska M
Acta Pol Pharm; 1994; 51(4-5):393-401. PubMed ID: 7701953
[TBL] [Abstract][Full Text] [Related]
24. [Comparative characteristics of the activity of lithium preparations and anti-arrhythmia agents in strophanthin, calcium chloride and barium chloride arrhythmias in an experiment].
Galenko-Iaroshevskiĭ PA; Tikhonov AV
Farmakol Toksikol; 1985; 48(2):64-8. PubMed ID: 3996574
[TBL] [Abstract][Full Text] [Related]
25. [Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].
Gorbunova VV; Gorbunov NP
Farmakol Toksikol; 1983; 46(3):48-50. PubMed ID: 6861988
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696).
Nakagawa Y; Sugai T; Chin WP; Shibuya T; Hashimoto K; Imai S
Arzneimittelforschung; 1984; 34(2):194-9. PubMed ID: 6144313
[TBL] [Abstract][Full Text] [Related]
27. [The anti-arrhythmic activity of quinuclidine derivatives].
Svistov AS; Skorobogatov VI
Eksp Klin Farmakol; 1994; 57(5):20-1. PubMed ID: 7696896
[TBL] [Abstract][Full Text] [Related]
28. [Anti-arrhythmia properties of marcaine].
Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV; Senova ZP; Liubushkina TE
Biull Eksp Biol Med; 1983 Sep; 96(9):64-7. PubMed ID: 6616058
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
Fekete MI; Elekes I; Kürti M; Borvendég J
Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):190-202. PubMed ID: 6111982
[TBL] [Abstract][Full Text] [Related]
30. The effect of alkyl substitution in drugs. XIX. Synthesis and pharmacological properties of a series of 1-(diarylmethoxy)-3-(isopropylamino)-2-propanol hydrochlorides showing antiarrhythmic activity.
De Vries J; Nauta WT; Timmerman H; van Hell G; Mulder D
Arzneimittelforschung; 1968 Sep; 18(9):1200-3. PubMed ID: 5755937
[No Abstract] [Full Text] [Related]
31. [New ethylenediamine derivatives with anti-arrhythmic activity].
Giannini M; Boni P; Fedi M; Bonacchi G
Farmaco Sci; 1973 Jun; 28(6):429-47. PubMed ID: 4716495
[No Abstract] [Full Text] [Related]
32. [Coparative pharmacological study of new adrenergic beta receptor blocking aromatic derivatives of oxybutanolamine and trasicor].
Szegl J; Szabó J; Szentmiklósi J; Harsányi K; Korbonits D
Acta Pharm Hung; 1977 Jul; 47(4):145-54. PubMed ID: 21514
[No Abstract] [Full Text] [Related]
33. [Search for and study of antiarrhythmic substances among crown ethers].
Luk'ianenko NG; Bogatskiĭ AV; Iaroshenko IM; Vongaĭ VG; Nazarov EI
Farmakol Toksikol; 1984; 47(5):29-32. PubMed ID: 6238839
[TBL] [Abstract][Full Text] [Related]
34. New derivatives of amino alcohols with antiarrhythmic activity.
Eckstein M; Cegła M; Krupińska J; Cebo B; Michna M
Pol J Pharmacol Pharm; 1987; 39(3):317-22. PubMed ID: 3438214
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological study of 3-alkyl-5-(cycloalkoxymethyl)oxazolidines].
Staneva D; Chakŭrova L; Pulev A
Eksp Med Morfol; 1982; 21(3):148-54. PubMed ID: 7173107
[No Abstract] [Full Text] [Related]
36. [The anti-arrhythmia properties of thymogen].
Reznikov KM; Vinokurova OV; Alabovskiĭ VV; Vinokurov AA
Eksp Klin Farmakol; 1994; 57(6):31-3. PubMed ID: 7756955
[TBL] [Abstract][Full Text] [Related]
37. [The cardiotoxic properties of anti-arrhythmia agents].
Spasov AA; Gurova NA
Eksp Klin Farmakol; 1997; 60(2):20-3. PubMed ID: 9206561
[TBL] [Abstract][Full Text] [Related]
38. Arrhythmias and antiarrhythmic drugs: mechanism of action and structure-activity relationships II.
Morgan PH; Mathison IW
J Pharm Sci; 1976 May; 65(5):635-48. PubMed ID: 6770
[No Abstract] [Full Text] [Related]
39. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives].
Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI
Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403
[TBL] [Abstract][Full Text] [Related]
40. Propranolol analog with the natural monoterpene structure as a potent antiarrhythmic drug.
Librowski T; Filipek B; Czarnecki R; Beresewicz A; Karwatowska-Prokopczuk E
Acta Pol Pharm; 1998; 55(3):243-7. PubMed ID: 9735705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
